Carlyle Group Inc.
In its 13F for Q2 2026 (holdings as of June 30, 2026, filed August 7, 2026), Carlyle Group Inc. reported 19 stock positions worth $10.0 billion. Its top holding was Medline Class A (MDLN) at 73.8% of the portfolio, followed by Standardaero (SARO, 25.3%) and Phathom Pharmaceuticals (PHAT, 0.4%). Compared with Q1 2026, it opened 3 new positions, sold out of 4, added to 2 and reduced 2. The biggest buy was Sunpower (SPWR, shares +441%) and the biggest sale an exit from Cubesmart (CUBE).
- Most Recent 13F
- Q2 2026
- Location
- WASHINGTON, DC
- CIK
- 0001527166
- Portfolio Value
- $10.0B (Q2 2026)
- SEC Filing
- 0000898432-26-000602 ↗ filed Aug 7, 2026
Holdings Value
Holdings 19 stocks · $10.0B
| MDLN Medline Inc. Class A | 73.78% | 187,083,713 | $7.4B | No change |
| SARO Standardaero Inc. | 25.30% | 84,587,035 | $2.5B | No change |
| PHAT Phathom Pharmaceuticals Inc. | 0.38% | 3,496,808 | $37.9M | No change |
| INVH Invitation Homes Inc. | 0.20% | 662,900 | $20.0M | Reduce -0.2% |
| PONY Pony AI Inc. | 0.16% | 2,362,447 | $16.4M | No change |
| GETY Getty Images Holdings Inc. | 0.05% | 6,234,252 | $5.4M | No change |
| SPRB Spruce Biosciences Inc. | 0.02% | 38,620 | $2.1M | No change |
| SPWR Sunpower Inc. | 0.02% | 2,343,750 | $1.6M | Add +441.1% |
| ACET Adicet Bio Inc. | 0.02% | 184,295 | $1.6M | No change |
| FWRD Forward Air Corp. | 0.01% | 107,214 | $1.4M | No change |
| OKUR Onkure Therapeutics Inc. Class A | 0.01% | 269,895 | $1.2M | No change |
| DNUT Krispy Kreme Inc. | 0.01% | 340,748 | $1.2M | No change |
| QTTB Q32 Bio Inc. | 0.01% | 60,363 | $769K | Reduce -94.5% |
| REPX Riley Exploration Permian Inc. | 0.01% | 16,092 | $530K | New |
| NBIS Nebius Group NV | 0.01% | 1,846 | $510K | New |
| HOOD Robinhood Markets Inc. Class A | 0.00% | 4,733 | $475K | Add +40.2% |
| JSPR Jasper Therapeutics Inc. | 0.00% | 1,066,189 | $449K | No change |
| NABL N-Able Inc. | 0.00% | 93,732 | $344K | No change |
| METC Ramaco Resources Inc. Class A | 0.00% | 21,743 | $288K | New |
Portfolio Sells Q1 2026 → Q2 2026
Portfolio Buys Q1 2026 → Q2 2026
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 19 | $10.0B | MDLN, SARO, PHAT, INVH, PONY |
| Q1 2026 | 20 | $10.6B | MDLN, SARO, PHAT, PONY, INVH |
| Q4 2025 | 20 | $13.6B | MDLN, SARO, PHAT, PONY, INVH |
| Q3 2025 | 17 | $4.3B | SARO, PONY, PHAT, SPRB, INVH |
| Q2 2025 | 20 | $5.0B | SARO, SLNO, PHAT, PONY, INVH |
| Q1 2025 | 23 | $3.8B | SARO, SLNO, WRD, PHAT, PONY |
| Q4 2024 | 27 | $4.1B | SARO, SLNO, WRD, PONY, PHAT |
| Q3 2024 | 26 | $954.2M | QDEL, SLNO, GTM, PHAT, QTTB |
| Q2 2024 | 31 | $1.1B | QDEL, GTM, SLNO, GDS, PHAT |
| Q1 2024 | 32 | $1.6B | QDEL, GTM, SLNO, VTRU, VRNA |